Vaccine News and Research

Latest Vaccine News and Research

Department of Health to continue H1N1 vaccination clinics every Saturday in Pennsylvania

In an effort to ensure that Pennsylvania's citizens are protected against the H1N1 flu virus, the Department of Health will continue public vaccination clinics at all 60 state health centers every Saturday through Feb. 6 from 9 a.m. to noon.

23 Jan 2010

USPTO issues new patent for Advaxis' intellectual property portfolio

The U.S. Patent and Trademark Office (USPTO) issued today patent 7,635,479, "Compositions and Methods for Enhancing the Immunogenicity of Antigens,” by Dr. Yvonne Paterson, et al, which is assigned to the Trustees of the University of Pennsylvania and licensed to Advaxis, Incorporated (OTCBB: ADXS).

22 Jan 2010

GSK announces new initiatives for addressing healthcare challenges in the world's poorest countries

Andrew Witty, Chief Executive of GlaxoSmithKline, today announced a series of new initiatives targeted at further transforming the company's approach to diseases that disproportionately affect the world's poorest countries. His announcements build on commitments made in 2009 to work in partnership, expand access to medicines and encourage new research into neglected tropical diseases.

22 Jan 2010

New study indicates viruses employ a novel mechanism to spread more quickly than thought possible

New video footage of a virus infecting cells is challenging what researchers have long believed about how viruses spread, suggesting that scientists may be able to create new drugs to tackle some viruses.

22 Jan 2010

Controversy around Merck's pricing for its AIDS drug Isentress

The controversy around Merck and Co. Pharmaceuticals’ pricing for its key AIDS drug Isentress — at nearly $13,000 per patient yearly, the most expensive first line AIDS therapy on the US market today — continued this week following Merck’s reaction to recent public criticism of its AIDS drug pricing. Merck ramped up its damage control PR efforts, issuing a press release that sought to rewrite the history of Isentress and deflect attention by claiming AIDS Healthcare Foundation has been unfairly attacking them.

22 Jan 2010

Findings may provide new insights into diabetes; suggest novel targets for drug intervention

The neuropeptide corticotropin-releasing factor (CRF) makes cameo appearances throughout the body, but its leading role is as the opening act in the stress response, jump-starting the process along the hypothalamus-pituitary-adrenal (HPA) axis. Researchers at the Salk Institute for Biological Studies have found that CRF also plays a part in the pancreas, where it increases insulin secretion and promotes the division of the insulin-producing beta cells.

22 Jan 2010

Clorox urges organizations to equip with flu prevention educational tools to prevent virus spread

Seasonal flu activity typically peaks in January or later, according to the Centers for Disease Control and Prevention (CDC), and the flu virus can spread as late as May. On top of the rising seasonal flu activity, this season the 2009 H1N1 virus is also circulating. Organizations – and particularly mass transportation systems where many people pass through daily – need to be ready to combat and help prevent the further spread of both flu viruses this winter and spring.

22 Jan 2010

Men who buy fake internet drugs for ED problems face significant health risks

Men who buy fake internet drugs for erection problems can face significant risks from potentially hazardous contents and bypassing healthcare systems could leave associated problems like diabetes and high blood pressure undiagnosed.

21 Jan 2010

Researchers explain how HSV dismantles host's defense systems

A viral infection is like an uninvited, tenacious houseguest in the cell, using a range of tricks to prevent its eviction. Researchers at the Salk Institute for Biological Studies have identified one of the key proteins allowing herpes simplex virus (HSV) DNA to fly under the radar of their hosts' involuntary hospitality.

21 Jan 2010

Sinovac Biotech announces financial update, new joint ventures and developments

Sinovac Biotech Ltd. (SVA) ("Sinovac" or the "Company"), a leading China-based vaccine manufacturer, today announced the following recent developments.

21 Jan 2010

New research suggests prolong breastfeeding is critical for reducing risk of gastroenteritis in infants

For African infants with HIV-positive mothers, reducing exposure to breast milk can lower the rate of HIV transmission. But new research suggests that longer periods of breastfeeding—at least 6 months—are critical for reducing the risk of potentially fatal gastroenteritis.

21 Jan 2010

IMUC’s ICT-107 vaccine product candidate targets cancer stem cells

ImmunoCellular Therapeutics today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs). This suggests that IMUC’s lead cancer vaccine product candidate ICT-107, which targets those antigens, may effectively target not only the cells that make up the bulk of certain cancerous tumors, but also the CSCs that are widely believed to give rise to them and cause their recurrence.

21 Jan 2010

Getting vaccinated within five days after exposing to chickenpox prevents chickenpox

For people who haven't had chickenpox and are exposed to an ill family member, getting vaccinated within five days can reduce the risk of developing chickenpox—or at least reduce the severity of disease, reports a study in the January issue of The Pediatric Infectious Disease Journal.

21 Jan 2010

Study: PrEP treatment offers protection against HIV transmission in humanized mice

Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.

21 Jan 2010

Discovery of new class of compounds may help fight hepatitis C

Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus’s propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.

21 Jan 2010

SVA plans to sell 8,650,000 common shares in an underwritten public offering

Sinovac Biotech Ltd. ( SVA), a leading China-based vaccine manufacturer, today announced that it plans to sell, subject to market and other conditions, 8,650,000 common shares of the company in an underwritten public offering.

21 Jan 2010

BIO commends GSK and Alnylam’s efforts to foster new therapies for neglected diseases

The Biotechnology Industry Organization (BIO) applauds the joint efforts of BIO members GlaxoSmithKline and Alnylam Pharmaceuticals to encourage research to accelerate medical therapies for neglected diseases and today’s announcement of the selection of BIO Ventures for Global Health (BVGH) as the administrator of the Intellectual Property (IP) Pool.

21 Jan 2010

Medical student receives 2009 Lucien Rubenstein Award

The American Brain Tumor Association has announced that Alexander Ksendzovsky, a third-year medical student at the Chicago Medical School of Rosalind Franklin University in North Chicago, is the 2009 Lucien Rubenstein Award recipient.

21 Jan 2010

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

21 Jan 2010

Healthcare industry in Asia Pacific to grow up to US$349 billion by 2012

Frost & Sullivan believes that the healthcare industry is undergoing a paradigm shift from "sickness care" to "wellness". Focused on the 5 Ps – Preventive, Pre-emptive, Personalized, Predictive and Personal Responsibility – the healthcare industry in Asia Pacific is expected to grow to US$349 billion by 2012.

21 Jan 2010

Vaccine News and Research

Latest Vaccine News and Research

Department of Health to continue H1N1 vaccination clinics every Saturday in Pennsylvania

USPTO issues new patent for Advaxis' intellectual property portfolio

GSK announces new initiatives for addressing healthcare challenges in the world's poorest countries

New study indicates viruses employ a novel mechanism to spread more quickly than thought possible

Controversy around Merck's pricing for its AIDS drug Isentress

Findings may provide new insights into diabetes; suggest novel targets for drug intervention

Clorox urges organizations to equip with flu prevention educational tools to prevent virus spread

Men who buy fake internet drugs for ED problems face significant health risks

Researchers explain how HSV dismantles host's defense systems

Sinovac Biotech announces financial update, new joint ventures and developments

New research suggests prolong breastfeeding is critical for reducing risk of gastroenteritis in infants

IMUC’s ICT-107 vaccine product candidate targets cancer stem cells

Getting vaccinated within five days after exposing to chickenpox prevents chickenpox

Study: PrEP treatment offers protection against HIV transmission in humanized mice

Discovery of new class of compounds may help fight hepatitis C

SVA plans to sell 8,650,000 common shares in an underwritten public offering

BIO commends GSK and Alnylam’s efforts to foster new therapies for neglected diseases

Medical student receives 2009 Lucien Rubenstein Award

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

Healthcare industry in Asia Pacific to grow up to US$349 billion by 2012

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in